I can usually tell, in five minutes, whether a practice has an intake problem. I open one established patient at random and look at visit one. If that note is a sketch, the rest of the chart is a sketch with better dates.
Follow-ups get the attention because they are the daily grind. The intake is the document everyone else will trust. Covering clinicians. Auditors. The therapist you add in month four. The NP who sees them when you are out. They will not re-take the history. They will copy what you wrote.
What a thin intake actually costs you
A missing prior med trial becomes a second trial of the same SSRI next spring. Skip a family history of bipolar and you start an antidepressant you would have held. Skip the substance line and you write a benzo you would have thought twice about. None of that shows up as “intake quality” on a dashboard. It shows up as a messy year.
Payers do this too. Medical necessity for visit 14 is often justified by the story you told in visit 1: duration, function, failed outpatient, why this level of care. If visit 1 says “anxiety, start sertraline,” visit 14 has nothing to stand on except habit.
I have watched groups spend weeks arguing about AI note quality on follow-ups when the real problem is that the first visit never established the patient.
The sections people rush
History of present illness that starts at this week. You need onset, course, what they already tried, and what “better” would mean. If they have been depressed since the divorce in 2019 and you write “feeling down lately,” you have invented a new illness.
Prior meds without doses or why they stopped. “Tried Lexapro, didn’t like it” is how you repeat Lexapro. “Escitalopram 10 mg, two weeks, agitation, stopped” is a fact.
Allergies and adverse effects, separately. People say “allergy” when they mean nausea. The next prescriber will treat that word as gospel.
Social and substance in one shrug. Housing, weapons, cannabis daily, alcohol “socially” that is a six-pack. This is the stuff that changes the plan and never appears in a 12-minute intake because the clock won.
A risk section that is only “denies SI/HI.” If you did not ask about plan, means, prior attempts, and what they would do this weekend if it got worse, you did not assess risk. You cleared a checkbox.
You cannot finish an intake in the same shape as a follow-up
This is where tools get blamed. An ambient draft will follow the visit you ran. If the visit was a long med-management appointment pretending to be an evaluation, the note will look like a follow-up with a new patient name.
Block the time. Tell the front desk an intake is an intake. If you only have 25 minutes, you do not have an intake. You have a first prescription and a debt you will pay later.
I would rather see a planned second visit to finish history than a signed chart that pretends you finished. Write “developmental history incomplete; scheduled” and mean it. Do not paste a normal childhood you did not take.
What I look for when I spot-check
Open the intake. Can I tell why they came, what they have already tried, what is dangerous, and why you started what you started? If I can, the later notes have a spine. If I cannot, no scribe and no template will save the follow-ups. They will only produce cleaner versions of a missing story.
Nextvisit can draft from the visit and drop the result into whatever intake template you already use. That is useful when the visit itself was an evaluation. It will not grow history you never asked. The first visit is still the one you have to run like it matters, because every other note in that chart is going to believe you.